X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5264) 5264
Newspaper Article (200) 200
Newsletter (173) 173
Book Chapter (109) 109
Magazine Article (21) 21
Book / eBook (10) 10
Conference Proceeding (7) 7
Dissertation (5) 5
Publication (5) 5
Transcript (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3833) 3833
science & technology (3581) 3581
life sciences & biomedicine (3423) 3423
drug therapy, combination (3336) 3336
immunotherapy (2512) 2512
female (1953) 1953
male (1780) 1780
middle aged (1309) 1309
oncology (1245) 1245
adult (1214) 1214
animals (1172) 1172
cancer (1091) 1091
treatment outcome (940) 940
aged (886) 886
combination therapy (827) 827
immunology (788) 788
care and treatment (741) 741
chemotherapy (731) 731
drug therapy (651) 651
mice (598) 598
health aspects (570) 570
research (535) 535
antineoplastic agents - therapeutic use (508) 508
abridged index medicus (464) 464
immunosuppressive agents - therapeutic use (460) 460
drug combinations (454) 454
immunotherapy - methods (454) 454
clinical trials (444) 444
tumors (441) 441
pharmacology & pharmacy (427) 427
analysis (414) 414
adolescent (411) 411
melanoma (382) 382
cancer therapies (379) 379
transplantation (371) 371
medicine & public health (356) 356
antineoplastic combined chemotherapy protocols - therapeutic use (336) 336
metastasis (335) 335
surgery (333) 333
antibodies, monoclonal - therapeutic use (331) 331
time factors (323) 323
child (320) 320
combined modality therapy (312) 312
clinical trials as topic (306) 306
review (302) 302
medicine, research & experimental (292) 292
research & experimental medicine (292) 292
antineoplastic agents - administration & dosage (289) 289
patients (286) 286
follow-up studies (284) 284
retrospective studies (280) 280
medical research (276) 276
prognosis (270) 270
apoptosis (256) 256
drug administration schedule (256) 256
lymphocytes (247) 247
t cells (247) 247
cell line, tumor (246) 246
hematology (232) 232
neoplasms - drug therapy (228) 228
neoplasms - therapy (227) 227
aged, 80 and over (221) 221
dose-response relationship, drug (215) 215
dosage and administration (214) 214
medicine (210) 210
usage (205) 205
antigens (204) 204
neoplasms - immunology (198) 198
cytotoxicity (192) 192
young adult (191) 191
drug synergism (190) 190
immunosuppression (190) 190
proteins (185) 185
studies (181) 181
corticosteroids (180) 180
neoplasm metastasis (177) 177
disease models, animal (175) 175
cytokines (174) 174
patient outcomes (173) 173
antineoplastic agents (172) 172
immune system (168) 168
survival analysis (167) 167
infectious diseases (166) 166
immunosuppressive agents - administration & dosage (165) 165
prospective studies (164) 164
general & internal medicine (163) 163
immune response (163) 163
immunosuppressive agents (163) 163
medicine, experimental (162) 162
monoclonal antibodies (162) 162
research article (162) 162
drug resistance (161) 161
kidneys (161) 161
drugs (160) 160
child, preschool (159) 159
combination (159) 159
melanoma - drug therapy (159) 159
risk factors (159) 159
lymphocytes t (158) 158
survival rate (158) 158
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5520) 5520
Russian (93) 93
German (70) 70
French (62) 62
Japanese (50) 50
Polish (18) 18
Spanish (13) 13
Italian (9) 9
Chinese (8) 8
Norwegian (4) 4
Portuguese (4) 4
Dutch (3) 3
Hungarian (3) 3
Romanian (3) 3
Korean (2) 2
Swedish (2) 2
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell (Cambridge), ISSN 0092-8674, 02/2017, Volume 168, Issue 4, pp. 707 - 723
Journal Article
Frontiers in immunology, ISSN 1664-3224, 08/2019, Volume 10, pp. 2022 - 2022
Journal Article
Seminars in cancer biology, ISSN 1044-579X, 02/2018, Volume 48, pp. 91 - 103
.... The clinical success of cancer immunotherapies targeting T-cell immune checkpoint receptors PD-1/PD-L1 has demonstrated the importance of immunoevasion as a hallmark of cancer... 
Hematology, Oncology and Palliative Medicine | Inhibitors | PI3K | Tumor microenvironment | Targeted therapy | Immunotherapy | mTOR | AKT | Combination therapy | Immunotherapeutic resistance | Life Sciences & Biomedicine | Oncology | Science & Technology | Prevention | Medical research | Medical colleges | Care and treatment | Medicine, Experimental | Research institutes | Drug therapy | T cells | Cells | Cancer | Index Medicus
Journal Article